The new CT/NG test complements the test portfolio for sexually transmitted infections (STI)
Qualitative test for the detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG)*
Reliable test results with the Vivalytic CT/NG test*
The Bosch Vivalytic CT/NG Test is an automated qualitative in-vitro diagnostic test for the DNA detection of Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) to aid in the diagnosis of sexually transmitted infections in symptomatic and asymptomatic individuals.
Chlamydia trachomatis and Neisseria gonorrhoeae are among the most common sexually transmitted pathogens. The number of new cases amounts to 129 million (CT) and 82 million (NG) per year worldwide (WHO figures for 2020). (1)
An infection often progresses without symptoms, which is problematic as those affected are not aware that they can infect others. If left untreated, these infections can lead to serious complications such as pelvic inflammatory disease, infertility, pregnancy complications and an increased risk of HIV transmission. Therefore, it is important to get tested regularly for Chlamydia trachomatis and Neisseria gonorrhoeae to ensure early diagnosis and treatment and to minimize the spread of infections.
With the Vivalytic CT/NG test, it is possible to test patients directly on site. As the results are available shortly after the sample is taken, treatment can be started immediately, which reduces the negative effects of an undetected infection. There is no need to transport samples to a specialist laboratory.
Pathogens detectable with Vivalytic CT/NG
- Chlamydia trachomatis
- Neisseria gonorrhoeae
Vivalytic CT/NG- Fast laboratory testing for outbreak containment
- Only a few steps from sample to result
- No further laboratory equipment needed
- Reduced risk of infection for the user
(1)https://www.who.int/news-room/fact-sheets/detail/sexually-transmitted-infections-(stis)
*Currently under development. Available as Research Use Only (RUO). Not for use in diagnostic procedures.
The advantages at a glance
Vivalytic stands for high efficiency and safety with minimum effort. The unique Vivalytic platform provides ideal assistance for everyday work in clinics, practices, and laboratories.
Comprehensive results
The Vivalytic CT/NG test enables rapid screening of patients for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) at the point of care.
High usability
The minimalistic design, easy handling and comprehensive depiction of the results ensure a high level of usability.
Easy handling
Like all Vivalytic tests, the Vivalytic CT/NG test is fully automated. This allows for fewer work steps, saving valuable time.
Only few steps from sample to result
What exactly happens in the Vivalytic Analyser?
The Vivalytic Analyser automates complex, molecular diagnostic processes that previously had to be carried out manually. This promotes high safety and quick availability of the test results.
| 1. Step | 2. Step | 3. Step | 4. Step | 5. Step |
|---|---|---|---|---|
|
1. Step
Preparing the sample
|
2. Step
Cell lysis
|
3. Step
Extraction of the nucleic acid
|
4. Step
DNA amplification
|
5. Step
Bio-analytical detection
|
1. Step
|
2. Step
|
3. Step
|
4. Step
|
5. Step
|
|
1. Step
Samples are processed reliably.
|
2. Step
The external membrane of the cells is broken down through ultrasound.
|
3. Step
The nucleic acid (DNA/RNA) is purified for the PCR amplification.
|
4. Step
Specific DNA sequences are multiplied using PCR.
|
5. Step
The amplified DNA is identified by detecting a fluorescence or chemiluminescence signal.
|
Get the new PCR test with Vivasuite
You can conveniently carry out updates remotely via the digital platform for Vivalytic products. This means that you will always have the latest tests available.